Trending Now
Brickell Biotech Inc. (NASDAQ:BBI) Announce dosing of First Patent In Cardigan...
Brickell Biotech Inc. (NASDAQ:BBI) has dosed the first patient in the second US vital Phase 3 clinical trials ("Cardigan II study"). The...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
This is where Invesco QQQ Trust Series 1 (QQQ) is headed...
After an attempt higher, the QQQ’s are getting hit again this morning now trading in negative territory as the market leader NVDA...
MAKE IT MODERN
LATEST REVIEWS
Ocugen Inc (NASDAQ: OCGN) Announced the Presentation of its Latest Advancements...
Ocugen Inc (NASDAQ: OCGN) recently disclosed that its chief executive officer, Dr. Shankar Munsunuri was to speak at the Nobble Capital Markets' Eighteenth Annual...
MAKE IT MODERN
PERFORMANCE TRAINING
Porch Group, Inc. (PRCH): Strong Q3 Performance Drives 55% Stock Surge Amid Strategic Wins...
Porch Group, Inc. (NASDAQ: PRCH), a comprehensive homeowners insurance and vertical software platform, experienced a remarkable 55.36% increase in its stock price,...
Ocugen Inc. (NASDAQ: OCGN) and Bharat Biotech Announce Study Results Showing COVAXIN Can Neutralize...
Ocugen Inc. (NASDAQ: OCGN) and its Bharat Biotech have announced results of a study carried at Emory University showing that sera from participants that...
Coronavirus fears keep pushing SPY down
Futures are down this morning. The SPY is currently sitting at 324.98 in the premarket and has been moving up in the...
Moderna Inc (NASDAQ:MRNA) Clinches A Deal For $1.525 Billion To Supply 100 Million Doses...
Moderna Inc (NASDAQ:MRNA) received an order from the US Government to supply 100 million doses of its mRNA-1273 vaccine. The US Government can also...
ADiTx Therapeutics Inc. (NASDAQ:ADTX) Completed Validation Of Studies of AditxtScore™ for COVID-19
The primary mission of ADiTx Therapeutics Inc. (NASDAQ:ADTX), is to enhance people’s immune systems through immune monitoring and reprogramming. However, it has been working...
MAKE IT MODERN
